Summary:
The There appears to be a relationship between hormones and ovarian tumors as the ovaries themselves participate in hormone production.
Such a relationship has been suggested from clinical and experimental data about granulosa cell tumors (Butterworth, 1937; Traut et al, 1937; Muhlbock, 1953) . However, as other tumors are difficult to produce experimentally, few observations have been made.
In our department chemical carcinogens are imbedded in the ovarian parenchyma using the clipping method; this results in a high incidence of adenocarcinoma (Kato, 1973 (Kato, , 1974 (Kato, , 1975 .
In the present study, the authors produced experimental ovarian tumors with various chemical carcinogens using the clipping method. The influence of administration of hormones on this tumor production is discussed here.
Materials and Methods

Subjects
Wistar female rats weighing 150 to 180 grams were allowed to adapt to the environmental conditions in the laboratory for about 2 weeks before the experiment. Food and water were given freely.
Tumor production
Knots were made in size-3 black silk surgical thread of soft type at an interval of 0.5 to 1 mm. A chemical carcinogen, which had been melted in a small test tube 35 dipped in a silicon oil bath, was applied to each knot. Two such knots were imbedded in the ovarian parenchyma of each rat.
Chemical carcinogens
There are several hundred carcinogens. The author used 9, 10-dimethyl-1, 2-benzanthracene (DM B A) , 20 -methylcholanthrene (20 -MC), 3, 4 -benzpyene (Benz -p) an aromatic hydrocarbon, and 4-nitroquinolin-N-oxide (4 NQO) a heterocyclic compound.
Hormones
Five hormones were used : Estriol-depot by the chemical carcinogens.
The term " solid tumor" refers to all tumors which are entirely solid and cystic tumors which are partially fluid filled.
Tumor incidence is shown in Table 2 . Among the four carcinogens, the incidence of solid tumors was the highest with DMBA; 15% up to the 20th week, 30% up to 30 th week, and 60% up to the 49 th week. A similar pattern did not exist for cystic tumors.
The incidence of cystic tumor was rather low in the DMBA group. Among the animals sacrificed in the 40 th week, the incidence of solid tumor was high in the 20-MC group, similar to the DMBA group, but was very low in the Benz-P and 4 NQO groups (4% and 6.6%, respectively).
Incidence of tumors with various hormones A) Dosage and administration method of hormones
To determine the dosage of hormones, a pre-test was performed by selecting several doses calculated from human doses. The maximal dose that did not cause depilation, reduction of body weight, or death was thus determined.
The change in the vaginal smears of the rats was used as an index for the estrogen preparation in the pre-test.
It was observed that an intravascular injection of 10 mg of Estrioldepot kept the rats in a state of estrus for at least 1 week longer than the control (Fig. 1 , Photo 1). Because a solid tumor was observed in the 10 th week in the pre-test, administration of a drug was started in the 8 th week (table 3) . B) Assay The above-described clipping method was employed for producing tumors. DMBA, which yielded the highest incidence of tumors, was used as the chemical carcinogen.
For unifying the influence on the incidence of tumors, the experiment was performed under uniform conditions. A total of 671 rats were used: 135 for the In the DMBA control group solid tumors were first noted in the 10 th week (5%), with the incidence rising to 62% by the 40 th week. This was not significantly different from the results of the pre-test.
In the ACH group, tumor incidence (ii) Incidence of cystic tumor Cystic tumors are sometimes difficult to classify pathomorphologically into nonneoplasma and neoplasma.
The term "cystic tumor" here refers to one in which a cystic change is caused in a DMBA-treated ovary almost without the normal ovarian parenchyma (Photo 2). Fig. 3 shows the change in incidence compared with the control. In the ACH, Prog, HCG, and And. groups, the incidence of cystic tumor was high by the 10 th week and then subsequently declined. In the Est. group, however, the incidence of cystic tumor was very high even by the 30 th week.
(iii) Incidence of histological types of solid tumors
On the basis of histological examination, the solid tumors produced were divided into 3 types; fibroma (or adenofibroma), sarcoma, and adenocarcinoma. Fig. 4 shows the incidence of tumors caused by hormone administration by week. In the 10 th week, fibroadenoma (Photo 3) and adenocarcinoma (Photo 4) were each seen in 50 % of the cotrols. Among the hormone-treated groups the ACH group was similar in outcome to the control group. In that group the same two types of tumors were found in almost equal ratios. In the other hormone groups, solid tumors did not appear until the 10 th week, as described above.
The tumors produced by Est. were all of the adenofibroma type. In the 20 th week, solid tumors were seen in all of the Weight of the solid tumor produced (iv) Weight of solid tumors Sloid tumors were measured and weighed (Table 4 ). The average weight of tumors produced by ACH and Est. was generally greater than the control, but the other groups were not significantly different from the control. The largest tumors in each group were ; 42.5 g in the control, 146 g in the Est. group, 120 g in the ACH group, 38 g in the Frog. group, 50 g in the And. group, and 36 g in the HCG group.
The largest tumor was in Est. group (Photo 6)
Discussion
Retrospective and prospective approaches are usually employed to examine human tumor tissue and tumor production.
Observations of experimental ovarian tumors have shown that some tumors are produced by X-ray irradiation (Furth et al., 1936; Traut et al., 1937; Butterworth, 1937; Mandel et al., 1956) , some by intrasplenic ovarian transplantation (Biskind et al., 1944 (Biskind et al., , 1948 Iglesias et al., 1953; Gardner, 1957) , and others by chemical carcinogens or parabiosis. Tumor produced by X-ray or intrasplenic ovarian transplantation are primarily granulosa-theca cell tumors. There have been many reports on the genetic mechanism of this tumor and its relation to hormones based on experimental results.
Kato and Yakushi ji in our department established the clipping method for imbedding and fixing chemical carcinogens in the ovarian parenchyma to produce adenocarcinoma in 1973. Their report on production of these tumors was the first on this subject. Since that time there have been continuous studies on the histological genesis of the tumor and its properties with emphasis on inheritability (Yakushiji et al., 1979) .
The present study was one of these experiments.
The initial assumptin is that tumors can be produced by external hormones. In the 10 th or the 20 th week, changes in the remaining, controlateral ovaries were morphologically observed. When the rats were sacrificed, however, no special morphological changes were found except in a few cases. However, as cystic tumors appeared more in the treated group than in the control, and in several rats in the groups of Est. an HCG some changes were observed in the stroma of the regenerative gland mainly of ovarian follicles. There were also changes in the vaginal smears. These results seem closely related to the imbalance of the body endocrine adjusting mechanism caused by extrinsic hormones. These data also raise the question of transformation of tumor type. The solid tumors produced were of three types; adenof ibroma, adenocarcinoma. and sarcoma, The controls exhibited similar types. The type of tumor produced depends on the chemical carcinogen used, as the tumors were produced by local action of the chemical carcinogens.
The activity of DMBA appears to be rather strong, however, and it is possible that DMBA overrides the effect of extrinsic hormones.
All solid tumors in the Est. -given rats found in the 10 th week were of the adenof ibroma type. It is also interresting to note that most of the solid tumors which were produced by hormones, except ACH, and which appeared early, were of the adenof ibroma type. It can be said that in the process of producing adenocarcinoma as reported previously, fibroadenoma is a fundamental type which develops into adenocarcinoma or sarcoma, though the influence of extrinisic hormones cannot be denied as the time of appearance of the tumor differs greatly from that of the control.
Generally, the type of tumor and the immune mechanism cotribute to the proliferation or development of a tumor, and in the present experiment considerably larger tumors were produced in the groups of ACH and Est. This may be related to the growing rate of the tumor. ACH and Est. are known to accelerate proliferation of the tumor.
Recently hormone administration in chemotherapy for ovarian malignancies has been suggested.
Based on our experimental results, patients treated with ACH and Est. must be carefully followed.
Hormones have been linked to tumor production for some time. Clinical observations supported this link, including the increased incidence of uterine cancer in women after menopause and the relation between lactation and breast cancer. Experimental support was first reported early in this century by Lacassagne, Loeb, and other reserchers. They showed the increase in the incidence of breast cancer and uterine cancer in mice when ovarian follicle hormone was used. They also showed that ovarian excision prevented the appearance of breast cancer.
Various authors later showed that tumors were produced in various organs and tissues when hormones were used (Nelson, 1937 (Nelson, , 1939 Lipschutz, 1938; Iglesias, 1938; Moricard, 1938; Cauchoix, 1939) .
The effect of estrogen on mice, however, was not clarified in these early studies. Synthetic estrogen has been considered a cyclic type of carcinogenic hydrocarbon. It has been proposed that uterine cancer results from a direct action, similar to carcinogenic chemicals (Gardner, 1938 (Gardner, , 1939 Allen, 1941; Pan, 1948; Williams, 1953) . However, there has been no evidence to prove this until now. In an experiment by Taki et al. (1963) in which a tumor was produced by applying chemical carcinogens directly to the uterus, estrogen showed a significant accelerating effect, while progesterone and teststerone had inhibiting effects.
Although the present work involved ovarian rather than uterine tumors, the finding of high total incidence of cystic and solid tumors in the estrogen group, combined with the lower early incidence in progesterone and androgen groups, suggests the same links between hormones and tumor production.
